U.S. markets close in 5 hours 6 minutes
  • S&P 500

    3,372.18
    +36.71 (+1.10%)
     
  • Dow 30

    27,847.79
    +395.13 (+1.44%)
     
  • Nasdaq

    11,209.93
    +124.69 (+1.12%)
     
  • Russell 2000

    1,523.97
    +19.24 (+1.28%)
     
  • Crude Oil

    39.54
    +0.25 (+0.64%)
     
  • Gold

    1,890.40
    -12.80 (-0.67%)
     
  • Silver

    23.92
    -0.52 (-2.13%)
     
  • EUR/USD

    1.1736
    -0.0010 (-0.08%)
     
  • 10-Yr Bond

    0.6840
    +0.0390 (+6.05%)
     
  • GBP/USD

    1.2931
    +0.0071 (+0.55%)
     
  • USD/JPY

    105.5450
    -0.1100 (-0.10%)
     
  • BTC-USD

    10,776.67
    -67.54 (-0.62%)
     
  • CMC Crypto 200

    231.01
    +9.62 (+4.34%)
     
  • FTSE 100

    5,902.64
    +5.14 (+0.09%)
     
  • Nikkei 225

    23,185.12
    -353.98 (-1.50%)
     

Nordstrom (JWN) Looks Good: Stock Adds 5.6% in Session

Zacks Equity Research

Nordstrom, Inc. JWN was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.This reverses the recent trend for the company as the stock is now down 50.5% in the past one-month time frame.

The company has seen three negative estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Nordstrom currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Nordstrom, Inc. Price

Nordstrom, Inc. Price
Nordstrom, Inc. Price

Nordstrom, Inc. price | Nordstrom, Inc. Quote

A better-ranked stock in the Retail - Apparel and Shoes industry is Genesco Inc. GCO, which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Nordstrom, Inc. (JWN) : Free Stock Analysis Report
 
Genesco Inc. (GCO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research